Ignite Creation Date:
2024-05-05 @ 11:10 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01275248
Status:
TERMINATED
Last Update Posted:
2013-01-18
First Post:
2011-01-10
Brief Title:
Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder
Sponsor:
Transcept Pharmaceuticals
Organization:
Transcept Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01
Start Date Type:
None
Primary Completion Date:
2015-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2015-09
Completion Date Type:
ESTIMATED
First Submit Date:
2011-01-10
First Submit QC Date:
January 10 2011
Study First Post Date:
2011-01-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-01-16
Last Update Post Date:
2013-01-18
Last Update Post Date Type:
ESTIMATED